HEALTH● LOW2h ago · Sep 15, 2026, 5:50 PM
Psychedelic Drug Wins Third Phase 3 Anxiety Trial
Human Progress · global
“Definium Therapeutics has scored a third straight phase 3 win for its LSD formula, with the psychedelic significantly alleviating anxiety symptoms and setting up an FDA filing next year. While the Panorama trial did compare Definium’s DT120 ODT to placebo, the study also pitted the 100 μg dose against a 50 μg dose, which is […] The post Psychedelic Drug Wins Third Phase 3 Anxiety Trial appeared first on Human Progress.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoPennsylvania teen dies from measles complications, the state’s fourth deathNBC NewsHEALTH2h agoThe Community of Madrid announces an investigation after the Ramón y Cajal case and anticipates the result: “Lists are not falsified”El PaísHEALTH2h agoMeasles-related deaths in Pennsylvania rise to 4, health officials sayABC NewsHEALTH2h ago‘Breakbone fever’ is surging worldwide as mosquitoes expand into new territoriesThe Independent World